Nippon India ETF Nifty 50 Shariah BeES
Quality, valuation, momentum and financial trend all sit near 58/100 — no single factor dominates.
Buy zoneNippon India ETF Nifty 50 Shariah BeES earns a Hold from StocksWizard, with a blended score of 59/100. At ₹470.54 there isn't enough clean financial data for a confident fair-value estimate, so we hold back an intrinsic verdict. On 22.5x trailing earnings it sits roughly in line with the Other median of about 21.3x. The price is about 10% below its 52-week high of ₹522.78 and 7% above the low of ₹439.88. It clears 1 of 2 investability checks, with valuation 63 and momentum 52 on our 0–100 scales.
Analysis by Ankit Sharma · StocksWizard's own estimates from end-of-day public data — see how we calculate them. For information only, not investment advice.
1-year price
EOD · 2026-07-3152-week range
-9.99% from the 52-week high.
Price above both moving averages reads as an intact uptrend; below both, the trend is against you.
Verdict pillars
Hold59Our scores
Durability rewards strong, low-debt, profitable businesses; Valuation rewards stocks cheap vs their sector; Momentum rewards strong price trends.
Investability checklist
Not enough data to run the investability checklist.
Key fundamentals
Bull case vs bear case
Bull case
Opportunities
- Trading in our value buy zone versus sector peers.
Bear case
Weaknesses
- Price below its 200-day moving average (downtrend).
Nippon India ETF Nifty 50 Shariah BeES — frequently asked questions
Is Nippon India ETF Nifty 50 Shariah BeES a buy, hold or sell?
StocksWizard currently rates Nippon India ETF Nifty 50 Shariah BeES (SHARIABEES) a Hold, based on a blended score of 59/100 across valuation, quality, momentum and price trend. This is our own model-based view, not investment advice.
How has Nippon India ETF Nifty 50 Shariah BeES's share price performed?
Nippon India ETF Nifty 50 Shariah BeES is up 1% over three months, and last traded at ₹470.54. Past performance doesn't predict future returns.
More in Other
View allOur verdict, fair value, financial-health and checklist are StocksWizard's own estimates, computed from public end-of-day data using standard models (DCF, relative valuation, Altman Z, Piotroski). For information only — not investment advice or a recommendation. Verify independently before investing.